https://t.co/1ST4t7TM5p In our analysis, COX-2 inhibitors were associated with an increased risk of upper gastrointestinal AEs, especially abdominal pain. We also found an increased risk of cardiovascular AEs with COX-2 inhibitors, namely hypertension, he
RT @CanGovSciPubs: Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. https://t.co…
Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. https://t.co/1ZmCjtVBCX
Curtis, E.-Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and... https://t.co/K3HI8vkimT
RT @painmanwise: Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. https://t.co/u…
RT @painmanwise: Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. https://t.co/u…
Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. https://t.co/uVRzyCthy7